MCT2D Resource: Dosing Information for SGLT-2 Inhibitors and GLP-1 Receptor Agonists for Type 2 Diabetes

Key dosing information for SGLT2-I and GLP1-RAs including dose escalation, pen and needle RX considerations, proven benefits for ASCVD, CKD, HFrEF, HFpEF, and DKD.
Tags:
For ProvidersNon-videoPDFCreated-By-MCT2DPoint-of-care